Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

Chronic central administration of ghrelin reverses the effects of leptin

Abstract

OBJECTIVE: To determine whether chronic central administration of ghrelin can block the effects of leptin on food intake, adiposity, and plasma concentrations of metabolic parameters and hormones.

DESIGN: Intracerebroventricular (ICV) infusions of leptin (5 μg/day) for 7 days, with or without ghrelin (1.2 μg/day), in rats. Rats administered leptin plus ghrelin were divided into ad lib-fed and food-restricted groups.

MEASUREMENT: Body weight and food intake were monitored daily. Following killing on day 8, epididymal fat weight and fasting plasma concentrations of glucose, insulin, leptin, ghrelin, IGF-1, and adiponectin were determined.

RESULTS: ICV infusion of leptin decreased food intake by 39% and fat weight by 41%. Leptin decreased plasma concentrations of glucose, insulin, and leptin and increased plasma ghrelin levels. Central coadministration of ghrelin blocked the effects of leptin. Most of the effects of ghrelin were diminished by food restriction but ghrelin effect on adiposity and plasma insulin concentrations remained in food-restricted rats.

CONCLUSION: Chronic central administration of ghrelin reversed the effects of leptin, primarily by altering food intake, but ghrelin may have regulatory effects on adiposity and plasma insulin levels independent of feeding effect.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S . A role for ghrelin in the central regulation of feeding. Nature 2001; 409: 194–198.

    Article  CAS  Google Scholar 

  2. Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, Dhillo WS, Ghatei MA, Bloom SR . Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001; 86: 5992–5995.

    Article  CAS  Google Scholar 

  3. Tschőp M, Smiley DL, Heiman ML . Ghrelin induces adiposity in rodents. Nature 2000; 407: 908–913.

    Article  Google Scholar 

  4. Wren AM, Small CJ, Abbott CR, Dhillo WS, Seal LJ, Cohen MA, Batterham RL, Taheri S, Stanley SA, Ghatei MA, Bloom SR . Ghrelin causes hyperphagia and obesity in rats. Diabetes 2001; 50: 2540–2547.

    Article  CAS  Google Scholar 

  5. Guan XM, Yu H, Palyha OC, McKee KK, Feighner SD, Sirinathsinghji DJ, Smith RG, Van der Ploeg LH, Howard AD . Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Brain Res Mol Brain Res 1997; 48: 23–29.

    Article  CAS  Google Scholar 

  6. Shintani M, Ogawa Y, Ebihara K, Aizawa-Abe M, Miyanaga F, Takaya K, Hayashi T, Inoue G, Hosoda K, Kojima M, Kangawa K, Nakao K . Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes 2001; 50: 227–232.

    Article  CAS  Google Scholar 

  7. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM . Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995; 269: 543–546.

    Article  CAS  Google Scholar 

  8. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kern PA, Friedman JM . Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1995; 1: 1155–1161.

    Article  CAS  Google Scholar 

  9. Weigle DS, Bukowski TR, Foster DC, Holderman S, Kramer JM, Lasser G, Lofton-Day CE, Prunkard DE, Raymond C, Kuijper JL . Recombinant ob protein reduces feeding and body weight in the ob/ob mouse. J Clin Invest 1995; 96: 2065–2070.

    Article  CAS  Google Scholar 

  10. Schwartz MW, Seeley RJ, Campfield LA, Burn P, Baskin DG . Identification of targets of leptin action in rat hypothalamus. J Clin Invest 1996; 98: 1101–1106.

    Article  CAS  Google Scholar 

  11. Cheung CC, Clifton DK, Steiner RA . Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus. Endocrinology 1997; 138: 4489–4492.

    Article  CAS  Google Scholar 

  12. Muzumdar R, Ma X, Yang X, Atzmon G, Bernstein J, Karkanias G, Barzilai N . Physiologic effect of leptin on insulin secretion is mediated mainly through central mechanisms. FASEB J 2003; 17: 1130–1132.

    Article  CAS  Google Scholar 

  13. Kamohara S, Burcelin R, Halaas JL, Friedman JM, Charron MJ . Acute stimulation of glucose metabolism in mice by leptin treatment. Nature 1997; 389: 374–377.

    Article  CAS  Google Scholar 

  14. Minokoshi Y, Haque MS, Shimazu T . Microinjection of leptin into the ventromedial hypothalamus increases glucose uptake in peripheral tissues in rats. Diabetes 1999; 48: 287–291.

    Article  CAS  Google Scholar 

  15. Burcelin R, Kamohara S, Li J, Tannenbaum GS, Charron MJ, Friedman JM . Acute intravenous leptin infusion increases glucose turnover but not skeletal muscle glucose uptake in ob/ob mice. Diabetes 1999; 48: 1264–1269.

    Article  CAS  Google Scholar 

  16. Liu L, Karkanias GB, Morales JC, Hawkins M, Barzilai N, Wang J, Rossetti L . Intracerebroventricular leptin regulates hepatic but not peripheral glucose fluxes. J Biol Chem 1998; 273: 31160–31167.

    Article  CAS  Google Scholar 

  17. Small CJ, Kim MS, Stanley SA, Mitchell JR, Murphy K, Morgan DG, Ghatei MA, Bloom SR . Effects of chronic central nervous system administration of agouti-related protein in pair-fed animals. Diabetes 2001; 50: 248–254.

    Article  CAS  Google Scholar 

  18. Pal R, Sahu A . Leptin signaling in the hypothalamus during chronic central leptin infusion. Endocrinology 2003; 144: 3789–3798.

    Article  CAS  Google Scholar 

  19. Cusin I, Rohner-Jeanrenaud F, Stricker-Krongrad A, Jeanrenaud B . The weight-reducing effect of an intracerebroventricular bolus injection of leptin in genetically obese fa/fa rats. Reduced sensitivity compared with lean animals. Diabetes 1996; 45: 1446–1450.

    Article  CAS  Google Scholar 

  20. Lin CY, Higginbotham DA, Judd RL, White BD . Central leptin increases insulin sensitivity in streptozotocin-induced diabetic rats. Am J Physiol Endocrinol Metab 2002; 282: E1084–E1091.

    Article  CAS  Google Scholar 

  21. Date Y, Nakazato M, Hashiguchi S, Dezaki K, Mondal MS, Hosoda H, Kojima M, Kangawa K, Arima T, Matsuo H, Yada T, Matsukura S . Ghrelin is present in pancreatic alpha-cells of humans and rats and stimulates insulin secretion. Diabetes 2002; 51: 124–129.

    Article  CAS  Google Scholar 

  22. Zhang Y, Hufnagel C, Eiden S, Guo KY, Diaz PA, Leibel R, Schmidt I . Mechanisms for LEPR-mediated regulation of leptin expression in brown and white adipocytes in rat pups. Physiol Genom 2001; 4: 189–199.

    Article  CAS  Google Scholar 

  23. Dunbar JC, Hu Y, Lu H . Intracerebroventricular leptin increases lumbar and renal sympathetic nerve activity and blood pressure in normal rats. Diabetes 1997; 46: 2040–2043.

    Article  CAS  Google Scholar 

  24. Hardie LJ, Guilhot N, Trayhurn P . Regulation of leptin production in cultured mature white adipocytes. Horm Metab Res 1996; 28: 685–689.

    Article  CAS  Google Scholar 

  25. Donahoo WT, Jensen DR, Yost TJ, Eckel RH . Isoproterenol and somatostatin decrease plasma leptin in humans: a novel mechanism regulating leptin secretion. J Clin Endocrinol Metab 1997; 82: 4139–4143.

    CAS  PubMed  Google Scholar 

  26. Tschõp M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML . Circulating ghrelin levels are decreased in human obesity. Diabetes 2001; 50: 707–709.

    Article  Google Scholar 

  27. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS . A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001; 50: 1714–1719.

    Article  CAS  Google Scholar 

  28. Kim MS, Yoon CY, Park KH, Shin CS, Park KS, Kim SY, Cho BY, Lee HK . Changes in ghrelin and ghrelin receptor expression according to feeding status. Neuroreport 2003; 14: 1317–1320.

    Article  CAS  Google Scholar 

  29. Toshinai K, Mondal MS, Nakazato M, Date Y, Murakami N, Kojima M, Kangawa K, Matsukura S . Upregulation of ghrelin expression in the stomach upon fasting, insulin-induced hypoglycemia, and leptin administration. Biochem Biophys Res Commun 2001; 281: 1220–1225.

    Article  CAS  Google Scholar 

  30. Carro E, Senaris R, Considine RV, Casanueva FF, Dieguez C . Regulation of in vivo growth hormone secretion by leptin. Endocrinology 1997; 138: 2203–2206.

    Article  CAS  Google Scholar 

  31. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K . Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402: 656–660.

    Article  CAS  Google Scholar 

  32. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF . A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995; 270: 26746–26749.

    Article  CAS  Google Scholar 

  33. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y . Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20: 1595–1599.

    Article  CAS  Google Scholar 

  34. Hotta K, Funahashi T, Bodkin NL, Ortmeyer HK, Arita Y, Hansen BC, Matsuzawa Y . Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 2001; 50: 1126–1133.

    Article  CAS  Google Scholar 

  35. Ahima RS, Flier JS . Leptin. Annu Rev Physiol 2000; 62: 413–437.

    Article  CAS  Google Scholar 

  36. Tritos NA, Kokkinos A, Lampadariou E, Alexiou E, Katsilambros N, Maratos-Flier E . Cerebrospinal fluid ghrelin is negatively associated with body mass index. J Clin Endocrinol Metab 2003; 88: 2943–2946.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by an NRL grant from the Ministry of Science and Technology (M1-0104-00-0103) and a grant from the Korean Ministry of Health & Welfare (03-PJ1-PG1-CH05-0005) and Asan Institute of Life Sciences (2002-326).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K-U Lee.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, MS., Namkoong, C., Kim, HS. et al. Chronic central administration of ghrelin reverses the effects of leptin. Int J Obes 28, 1264–1271 (2004). https://doi.org/10.1038/sj.ijo.0802647

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijo.0802647

Keywords

This article is cited by

Search

Quick links